Get in touch with Asawari

Submit

Thank you

About Asawari

Asawari has a broad academic background in life sciences, biochemistry and food science. She works in the Life Sciences and Chemistry team where she supports clients in a range of technology areas including precision medicine, gene therapy, bioinformatics, medical devices and diagnostics.

Prior to joining Keltie in 2022, Asawari worked in the patent litigation team of a leading City law firm for over six years where she worked on contentious matters within the pharmaceutical and biotech space. She also has experience working in a technology transfer office for three years where she enjoyed interacting with academic inventors and understanding the role of IP in the commercialisation of research.

 

Before moving to the UK, Asawari worked in a DNA sequencing laboratory in Seattle for around three years.

More
DSIT Sets Out R&D Investment

26.11.2025

DSIT Sets Out R&D Investment

The UK Department for Science, Innovation and Technology (DSIT) has published its R&D budget allocations for research agencies and bodies up to 2029/30. This is the first multi-year budget since 2022.

More
What it takes to reach FT Gold

18.06.2025

What it takes to reach FT Gold

Keltie is proud to announce its best-ever result in the Financial Times Europe’s Leading Patent Law Firms 2025, achieving five Gold rankings and one Silver. This performance places Keltie among the top ten firms in Europe once again and marks the seventh consecutive year of recognition since the rankings began.

Get in touch with Asawari

Submit

Thank you